Global Neuromodulation Devices and Implantable Infusion Pumps Market by Manufacturers, Regions, Type and Application, Forecast to 2023

An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.

Scope of the Report:
This report focuses on the Neuromodulation Devices and Implantable Infusion Pumps in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The production mainly distributed in two regions of USA: Puerto Rico (83%), Massachusetts (17%). Medtronic is the manufacturing giants in this field, taking about 83% of the USA production. Medtronic is the largest player with 83% production market, followed by Codman & Shurtleff (J&J) with 15% in 2015.

USA implantable infusion pumps consumption increased from 23.71 K units in 2011 to 28.69 K units in 2015, with an average growth rate of 3.85%. Cancer Treatment and chronic pain treatment are the major fields where implantable infusion pumps are frequently used. In 2015, 18.14 K units' implantable infusion pumps were used to relieve the pain of Cancer, accounting for 66.6% of the USA total consumption. 26% of implantable infusion pumps were used for chronic pain treatment.

With fast technology development and strong demand, implantable infusion pumps price kept relatively stable and changed from 9964 USD/Unit in 2011 to 9456 USD/Unit in 2015.

It is expected that the USA implantable infusion pumps comsumption will be 35 K Units in 2021 and the production revenue will reach 311 million USD. At the same time, the price may gradually decline. This industry is easily affected by the technological innovation and the policy.

The worldwide market for Neuromodulation Devices and Implantable Infusion Pumps is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Medtronic
Boston Scientific Corporation
St. Jude Medical
Synapse Biomedical
Nevro Corporation
Neuropace
Cyberonics
Autonomic Technologies
Avery Biomedical
Greatbatch Medical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Vagal Nerve Stimulation
Gastric Stimulation
Transcranial magnetic Stimulation
Transcutaneous Electrical Stimulation
Other

Market Segment by Applications, can be divided into
Parkinson's disease
Epilepsy
Pain
Other

There are 15 Chapters to deeply display the global Neuromodulation Devices and Implantable Infusion Pumps market.
Chapter 1, to describe Neuromodulation Devices and Implantable Infusion Pumps Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, with sales, revenue, and price of Neuromodulation Devices and Implantable Infusion Pumps, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Neuromodulation Devices and Implantable Infusion Pumps, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Neuromodulation Devices and Implantable Infusion Pumps market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Neuromodulation Devices and Implantable Infusion Pumps sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents

1 Market Overview
1.1 Neuromodulation Devices and Implantable Infusion Pumps Introduction
1.2 Market Analysis by Type
1.2.1 Spinal Cord Stimulation
1.2.2 Deep Brain Stimulation
1.2.3 Sacral Nerve Stimulation
1.2.4 Vagal Nerve Stimulation
1.2.5 Gastric Stimulation
1.2.6 Transcranial magnetic Stimulation
1.2.7 Transcutaneous Electrical Stimulation
1.2.8 Other
1.3 Market Analysis by Applications
1.3.1 Parkinson's disease
1.3.2 Epilepsy
1.3.3 Pain
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Boston Scientific Corporation
2.2.1 Business Overview
2.2.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 St. Jude Medical
2.3.1 Business Overview
2.3.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Synapse Biomedical
2.4.1 Business Overview
2.4.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Nevro Corporation
2.5.1 Business Overview
2.5.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Neuropace
2.6.1 Business Overview
2.6.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cyberonics
2.7.1 Business Overview
2.7.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Autonomic Technologies
2.8.1 Business Overview
2.8.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Avery Biomedical
2.9.1 Business Overview
2.9.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Greatbatch Medical
2.10.1 Business Overview
2.10.2 Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2017
3.3.2 Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Analysis by Regions
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Regions
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Regions (2013-2018)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Regions (2013-2018)
4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
4.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
4.5 South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
5 North America Neuromodulation Devices and Implantable Infusion Pumps by Countries
5.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
5.1.1 North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Countries (2013-2018)
5.1.2 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries (2013-2018)
5.2 United States Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
5.3 Canada Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
5.4 Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
6 Europe Neuromodulation Devices and Implantable Infusion Pumps by Countries
6.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
6.1.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries (2013-2018)
6.2 Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
6.3 UK Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
6.4 France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
6.5 Russia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
6.6 Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
7 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps by Countries
7.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries (2013-2018)
7.2 China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
7.3 Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
7.4 Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
7.5 India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
8 South America Neuromodulation Devices and Implantable Infusion Pumps by Countries
8.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
8.1.1 South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Countries (2013-2018)
8.1.2 South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
8.3 Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
8.4 Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
9 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps by Countries
9.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
9.3 UAE Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
9.4 Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
9.5 Nigeria Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
9.6 South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
10 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Type
10.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Market Share by Type (2013-2018)
10.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Market Share by Type (2013-2018)
10.2 Spinal Cord Stimulation Sales Growth and Price
10.2.1 Global Spinal Cord Stimulation Sales Growth (2013-2018)
10.2.2 Global Spinal Cord Stimulation Price (2013-2018)
10.3 Deep Brain Stimulation Sales Growth and Price
10.3.1 Global Deep Brain Stimulation Sales Growth (2013-2018)
10.3.2 Global Deep Brain Stimulation Price (2013-2018)
10.4 Sacral Nerve Stimulation Sales Growth and Price
10.4.1 Global Sacral Nerve Stimulation Sales Growth (2013-2018)
10.4.2 Global Sacral Nerve Stimulation Price (2013-2018)
10.5 Vagal Nerve Stimulation Sales Growth and Price
10.5.1 Global Vagal Nerve Stimulation Sales Growth (2013-2018)
10.5.2 Global Vagal Nerve Stimulation Price (2013-2018)
10.6 Gastric Stimulation Sales Growth and Price
10.6.1 Global Gastric Stimulation Sales Growth (2013-2018)
10.6.2 Global Gastric Stimulation Price (2013-2018)
10.7 Transcranial magnetic Stimulation Sales Growth and Price
10.7.1 Global Transcranial magnetic Stimulation Sales Growth (2013-2018)
10.7.2 Global Transcranial magnetic Stimulation Price (2013-2018)
10.8 Transcutaneous Electrical Stimulation Sales Growth and Price
10.8.1 Global Transcutaneous Electrical Stimulation Sales Growth (2013-2018)
10.8.2 Global Transcutaneous Electrical Stimulation Price (2013-2018)
10.9 Other Sales Growth and Price
10.9.1 Global Other Sales Growth (2013-2018)
10.9.2 Global Other Price (2013-2018)
11 Global Neuromodulation Devices and Implantable Infusion Pumps Market Segment by Application
11.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2013-2018)
11.2 Parkinson's disease Sales Growth (2013-2018)
11.3 Epilepsy Sales Growth (2013-2018)
11.4 Pain Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Growth Rate (2018-2023)
12.2 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Regions (2018-2023)
12.2.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.2.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.2.3 Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.2.4 South America Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.2.5 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
12.3 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Type (2018-2023)
12.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2018-2023)
12.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Type (2018-2023)
12.4 Neuromodulation Devices and Implantable Infusion Pumps Market Forecast by Application (2018-2023)
12.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2018-2023)
12.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Neuromodulation Devices and Implantable Infusion Pumps Picture
Table Product Specifications of Neuromodulation Devices and Implantable Infusion Pumps
Figure Global Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Types in 2017
Table Neuromodulation Devices and Implantable Infusion Pumps Types for Major Manufacturers
Figure Spinal Cord Stimulation Picture
Figure Deep Brain Stimulation Picture
Figure Sacral Nerve Stimulation Picture
Figure Vagal Nerve Stimulation Picture
Figure Gastric Stimulation Picture
Figure Transcranial magnetic Stimulation Picture
Figure Transcutaneous Electrical Stimulation Picture
Figure Other Picture
Figure Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Applications in 2017
Figure Parkinson's disease Picture
Figure Epilepsy Picture
Figure Pain Picture
Figure Other Picture
Figure United States Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure France Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure UK Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure China Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure India Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Neuromodulation Devices and Implantable Infusion Pumps Revenue (Value) and Growth Rate (2013-2023)
Table Medtronic Basic Information, Manufacturing Base and Competitors
Table Medtronic Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table St. Jude Medical Basic Information, Manufacturing Base and Competitors
Table St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synapse Biomedical Basic Information, Manufacturing Base and Competitors
Table Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Nevro Corporation Basic Information, Manufacturing Base and Competitors
Table Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Neuropace Basic Information, Manufacturing Base and Competitors
Table Neuropace Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cyberonics Basic Information, Manufacturing Base and Competitors
Table Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Autonomic Technologies Basic Information, Manufacturing Base and Competitors
Table Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Avery Biomedical Basic Information, Manufacturing Base and Competitors
Table Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Greatbatch Medical Basic Information, Manufacturing Base and Competitors
Table Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Type and Applications
Table Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Manufacturer (2016-2017)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturer in 2016
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturer in 2017
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Manufacturer (2016-2017)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2016
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturer in 2017
Figure Top 3 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Neuromodulation Devices and Implantable Infusion Pumps Manufacturer (Revenue) Market Share in 2017
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Regions (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Regions (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Regions (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions in 2013
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Regions in 2017
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure South America Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries in 2013
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries in 2017
Table North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018)
Table North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2013
Figure North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2017
Figure United States Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Canada Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Mexico Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Table Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018)
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2016
Figure Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2017
Figure Germany Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure UK Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure France Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Russia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Italy Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018)
Table Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries 2017
Table Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018)
Figure Asia-Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries 2017
Figure China Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Japan Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Korea Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure India Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Southeast Asia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure South America Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table South America Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018)
Table South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure South America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries in 2017
Table South America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018)
Table South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure South America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2017
Figure Brazil Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Argentina Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Colombia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Countries (2013-2018)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Countries in 2017
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Countries (2013-2018)
Table Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2013
Figure Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Countries in 2017
Figure Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure UAE Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Egypt Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure Nigeria Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Figure South Africa Neuromodulation Devices and Implantable Infusion Pumps Sales and Growth Rate (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Type (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Type (2013-2018)
Figure Global Spinal Cord Stimulation Sales Growth (2013-2018)
Figure Global Spinal Cord Stimulation Price (2013-2018)
Figure Global Deep Brain Stimulation Sales Growth (2013-2018)
Figure Global Deep Brain Stimulation Price (2013-2018)
Figure Global Sacral Nerve Stimulation Sales Growth (2013-2018)
Figure Global Sacral Nerve Stimulation Price (2013-2018)
Figure Global Vagal Nerve Stimulation Sales Growth (2013-2018)
Figure Global Vagal Nerve Stimulation Price (2013-2018)
Figure Global Gastric Stimulation Sales Growth (2013-2018)
Figure Global Gastric Stimulation Price (2013-2018)
Figure Global Transcranial magnetic Stimulation Sales Growth (2013-2018)
Figure Global Transcranial magnetic Stimulation Price (2013-2018)
Figure Global Transcutaneous Electrical Stimulation Sales Growth (2013-2018)
Figure Global Transcutaneous Electrical Stimulation Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2013-2018)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Application (2013-2018)
Figure Global Epilepsy Sales Growth (2013-2018)
Figure Global Pain Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue and Growth Rate (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Regions (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Regions (2018-2023)
Figure North America Sales Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
Figure Europe Sales Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
Figure Asia-Pacific Sales Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
Figure South America Sales Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
Figure Middle East and Africa Sales Neuromodulation Devices and Implantable Infusion Pumps Market Forecast (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Type (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Type (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Sales Forecast by Application (2018-2023)
Table Global Neuromodulation Devices and Implantable Infusion Pumps Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ãÿhsd1) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This 11 Beta-Hydroxysteroid Dehydrogenase Type 1 (11ãÿhsd1) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global a...

Ephrin Type A Receptor 2 (Eph Receptor A2 Or Epha2) Antagonistmarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Ephrin Type A Receptor 2 (Eph Receptor A2 Or Epha2) Antagonist Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and...

Glycine Transporter Type-1 (Glyt-1) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Glycine Transporter Type-1 (Glyt-1) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major regions su...

Inducible Nitric Oxide Synthase (Inos Or Type Ii Nos) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Inducible Nitric Oxide Synthase (Inos Or Type Ii Nos) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global an...

Neuronal Nitric Oxide Synthase (Nnos Or Type I Nos) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Neuronal Nitric Oxide Synthase (Nnos Or Type I Nos) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and ...

Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Proprotein Convertase Subtilisin/Kexin Type 9 (Pcsk9) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global an...

Type 1 Lysophosphatidic Acid Receptor (Lpa1) Inhibitormarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Type 1 Lysophosphatidic Acid Receptor (Lpa1) Inhibitor Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major r...

Voltage-Dependent T-Type Calcium Channel Blockersmarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Voltage-Dependent T-Type Calcium Channel Blockers Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major region...

Familial Hypercholesterolemia (Type Ii Hyperlipoproteinemiamarket Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Familial Hypercholesterolemia (Type Ii Hyperlipoproteinemia Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and ma...

Familial Chylomicronemia (Type I Hyperlipoproteinemia)Market Report 2019-2026 Production, Sales And Consumption Status And Prospects Professional Research

Published Date : Dec 2018

This Familial Chylomicronemia (Type I Hyperlipoproteinemia) Market report 2019-2026 focus on global and regional market, providing information on major players like manufacturers, suppliers, distributors, traders, customers, investors and etc., major types, major applications from global and major r...

 

Select License :

  • Single User : $3480
  • Multiple User : $5220
  • Corporate User : $6960

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.